Aqr Capital Management LLC Paratek Pharmaceuticals, Inc. Transaction History

Aqr Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.7 - $7.24 $122,740 - $189,072	-26,115 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.81 - $10.93 $44,339 - $71,165	-6,511 Reduced 19.96%	26,115 $178,000
Q4 2020 Feb 16, 2021	BUY	$4.58 - $7.14 $7,465 - $11,638	1,630 Added 5.26%	32,626 $204,000
Q3 2020 Nov 16, 2020	BUY	$4.19 - $6.69 $78,432 - $125,230	18,719 Added 152.47%	30,996 $168,000
Q2 2020 Aug 17, 2020	BUY	$2.97 - $5.22 $36,462 - $64,085	12,277 New	12,277 $64,000
Q2 2018 Aug 14, 2018	SELL	$10.2 - $13.9 $130,447 - $177,767	-12,789 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$12.65 - $18.85 $71,371 - $106,351	-5,642 Reduced 30.61%	12,789 $166,000
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $348,345 - $519,754	18,431	18,431 $463,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.